We are not currently accepting applications. Our next Research Funding round will take place in Spring 2025.

Our mission is to advance an increased quality of life for those affected by secondary breast cancer and we are uniquely placed to make this happen through our research, support and education programmes.

In our 2023 funding call, we are inviting proposals for research projects which deliver tangible near-time benefit to people living with secondary breast cancer. Patient benefit is defined as a positive effect on or change to the care, services, treatment, mental wellbeing or quality of life of the secondary breast cancer community.

Useful links


28 August 2023

Launch of funding call

30 October 2023

Letter of intent deadline

30 November 2023            

Deadline for full applications

December 2023

External review

February 2024

Research Committee makes funding recommendations

March 2024


Board of Trustees ratifies final funding decisions

Applicants are duly notified


If you would like to discuss the scope of the funding call and any planned applications, please email research@make2ndscount.co.uk 

Please provide the host institution contact details

Host institution
Main contact in Research Support Office
Lead applicant details
Co-applicant details
Co-applicant details

Applicant CVs must be provided. If there are more than 3 applicants, contact details and an explanation of roles and responsibilities can be attached as a separate page.

Please provide details of your research proposal

e.g. clinical, qualitative, statistical
200 words maximum
500 words maximum
500 words maximum
200 words maximum
300 words maximum
Please note: each research proposal must include a patient advocate
300 words maximum
300 words maximum
Please provide details

Please note: costings will be thoroughly interrogated during the application process and you may be asked to provide further details.

Please consider the following fields carefully

Further information

Additional supporting documentation can be uploaded such as a patient advocate supporting statement, illustration of study design or literature review